Literature DB >> 34663898

Predicting cancer outcomes with radiomics and artificial intelligence in radiology.

Kaustav Bera1,2, Nathaniel Braman1,3, Amit Gupta1,2, Vamsidhar Velcheti4, Anant Madabhushi5,6.   

Abstract

The successful use of artificial intelligence (AI) for diagnostic purposes has prompted the application of AI-based cancer imaging analysis to address other, more complex, clinical needs. In this Perspective, we discuss the next generation of challenges in clinical decision-making that AI tools can solve using radiology images, such as prognostication of outcome across multiple cancers, prediction of response to various treatment modalities, discrimination of benign treatment confounders from true progression, identification of unusual response patterns and prediction of the mutational and molecular profile of tumours. We describe the evolution of and opportunities for AI in oncology imaging, focusing on hand-crafted radiomic approaches and deep learning-derived representations, with examples of their application for decision support. We also address the challenges faced on the path to clinical adoption, including data curation and annotation, interpretability, and regulatory and reimbursement issues. We hope to demystify AI in radiology for clinicians by helping them to understand its limitations and challenges, as well as the opportunities it provides as a decision-support tool in cancer management.
© 2021. Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 34663898      PMCID: PMC9034765          DOI: 10.1038/s41571-021-00560-7

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   65.011


  149 in total

1.  Deep transfer learning-based prostate cancer classification using 3 Tesla multi-parametric MRI.

Authors:  Xinran Zhong; Ruiming Cao; Sepideh Shakeri; Fabien Scalzo; Yeejin Lee; Dieter R Enzmann; Holden H Wu; Steven S Raman; Kyunghyun Sung
Journal:  Abdom Radiol (NY)       Date:  2019-06

2.  Radiomics of Multiparametric MRI for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter Study.

Authors:  Zhenyu Liu; Zhuolin Li; Jinrong Qu; Renzhi Zhang; Xuezhi Zhou; Longfei Li; Kai Sun; Zhenchao Tang; Hui Jiang; Hailiang Li; Qianqian Xiong; Yingying Ding; Xinming Zhao; Kun Wang; Zaiyi Liu; Jie Tian
Journal:  Clin Cancer Res       Date:  2019-03-06       Impact factor: 12.531

3.  Exploring breast cancer response prediction to neoadjuvant systemic therapy using MRI-based radiomics: A systematic review.

Authors:  R W Y Granzier; T J A van Nijnatten; H C Woodruff; M L Smidt; M B I Lobbes
Journal:  Eur J Radiol       Date:  2019-11-06       Impact factor: 3.528

Review 4.  The Value of FDG PET/CT in Treatment Response Assessment, Follow-Up, and Surveillance of Lung Cancer.

Authors:  Sara Sheikhbahaei; Esther Mena; Anusha Yanamadala; Siddaling Reddy; Lilja B Solnes; Jason Wachsmann; Rathan M Subramaniam
Journal:  AJR Am J Roentgenol       Date:  2016-10-11       Impact factor: 3.959

5.  Radiogenomics: what it is and why it is important.

Authors:  Maciej A Mazurowski
Journal:  J Am Coll Radiol       Date:  2015-08       Impact factor: 5.532

6.  Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.

Authors:  Yanqi Huang; Zaiyi Liu; Lan He; Xin Chen; Dan Pan; Zelan Ma; Cuishan Liang; Jie Tian; Changhong Liang
Journal:  Radiology       Date:  2016-06-27       Impact factor: 11.105

7.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

8.  Radiogenomics Monitoring in Breast Cancer Identifies Metabolism and Immune Checkpoints as Early Actionable Mechanisms of Resistance to Anti-angiogenic Treatment.

Authors:  Shaveta Mehta; Nick P Hughes; Sonia Li; Adrian Jubb; Rosie Adams; Simon Lord; Lefteris Koumakis; Ruud van Stiphout; Anwar Padhani; Andreas Makris; Francesca M Buffa; Adrian L Harris
Journal:  EBioMedicine       Date:  2016-07-16       Impact factor: 8.143

9.  Prognostic Significance of CT-Attenuation of Tumor-Adjacent Breast Adipose Tissue in Breast Cancer Patients with Surgical Resection.

Authors:  Jeong Won Lee; Sung Yong Kim; Hyun Ju Lee; Sun Wook Han; Jong Eun Lee; Sang Mi Lee
Journal:  Cancers (Basel)       Date:  2019-08-08       Impact factor: 6.639

Review 10.  Hyperprogression under Immunotherapy.

Authors:  Maxime Frelaut; Christophe Le Tourneau; Edith Borcoman
Journal:  Int J Mol Sci       Date:  2019-05-30       Impact factor: 5.923

View more
  23 in total

1.  BPNSTs: In the eye of the beholder.

Authors:  Timothy J Kaufmann; Bradley J Erickson
Journal:  Neuro Oncol       Date:  2022-04-01       Impact factor: 12.300

2.  Discovery of Pre-Treatment FDG PET/CT-Derived Radiomics-Based Models for Predicting Outcome in Diffuse Large B-Cell Lymphoma.

Authors:  Russell Frood; Matthew Clark; Cathy Burton; Charalampos Tsoumpas; Alejandro F Frangi; Fergus Gleeson; Chirag Patel; Andrew F Scarsbrook
Journal:  Cancers (Basel)       Date:  2022-03-28       Impact factor: 6.639

3.  Radiomics Model for Frontotemporal Dementia Diagnosis Using T1-Weighted MRI.

Authors:  Benedetta Tafuri; Marco Filardi; Daniele Urso; Roberto De Blasi; Giovanni Rizzo; Salvatore Nigro; Giancarlo Logroscino
Journal:  Front Neurosci       Date:  2022-06-20       Impact factor: 5.152

4.  PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs.

Authors:  Liping Yang; Panpan Xu; Mengyue Li; Menglu Wang; Mengye Peng; Ying Zhang; Tingting Wu; Wenjie Chu; Kezheng Wang; Hongxue Meng; Lingbo Zhang
Journal:  Front Oncol       Date:  2022-06-21       Impact factor: 5.738

5.  A Multiparametric Method Based on Clinical and CT-Based Radiomics to Predict the Expression of p53 and VEGF in Patients With Spinal Giant Cell Tumor of Bone.

Authors:  Qizheng Wang; Yang Zhang; Enlong Zhang; Xiaoying Xing; Yongye Chen; Ke Nie; Huishu Yuan; Min-Ying Su; Ning Lang
Journal:  Front Oncol       Date:  2022-06-21       Impact factor: 5.738

6.  Predicting MGMT Promoter Methylation in Diffuse Gliomas Using Deep Learning with Radiomics.

Authors:  Sixuan Chen; Yue Xu; Meiping Ye; Yang Li; Yu Sun; Jiawei Liang; Jiaming Lu; Zhengge Wang; Zhengyang Zhu; Xin Zhang; Bing Zhang
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

7.  Classification of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Based on Radiomic Analysis.

Authors:  Xiaoliang Xu; Yingfan Mao; Yanqiu Tang; Yang Liu; Cailin Xue; Qi Yue; Qiaoyu Liu; Jincheng Wang; Yin Yin
Journal:  Comput Math Methods Med       Date:  2022-02-21       Impact factor: 2.238

8.  Prediction of Early Response to Immunotherapy: DCE-US as a New Biomarker.

Authors:  Raphael Naccache; Younes Belkouchi; Littisha Lawrance; Baya Benatsou; Joya Hadchiti; Paul-Henry Cournede; Samy Ammari; Hugues Talbot; Nathalie Lassau
Journal:  Cancers (Basel)       Date:  2022-03-04       Impact factor: 6.639

Review 9.  State of the Art and New Concepts in Giant Cell Tumor of Bone: Imaging Features and Tumor Characteristics.

Authors:  Anna Parmeggiani; Marco Miceli; Costantino Errani; Giancarlo Facchini
Journal:  Cancers (Basel)       Date:  2021-12-15       Impact factor: 6.639

10.  AI-Driven Image Analysis in Central Nervous System Tumors-Traditional Machine Learning, Deep Learning and Hybrid Models.

Authors:  A V Krauze; Y Zhuge; R Zhao; E Tasci; K Camphausen
Journal:  J Biotechnol Biomed       Date:  2022-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.